Company profile · free preview
SOPHiA GENETICS S.A.
SOPH · NASDAQ · Healthcare · Updated 11/18/2026
Five-year financials
| Fiscal year |
|---|
| Revenue |
| Net income |
| Diluted EPS |
| Operating cash flow |
| Free cash flow |
| Cash |
| Total debt |
Financials are being prepared.
Want the story behind these numbers? Ask Osiris anything about SOPHiA GENETICS S.A.'s filings — free.
Create free accountSOPHiA GENETICS S.A. return on capital (fiscal 2025)
ROIC
—
Return on capital
—
Return on equity
-110.0%
Return on assets
-49.6%
Gross margin
67.4%
Operating margin
-91.8%
Net debt / EBITDA
0.37x
SOPHiA GENETICS S.A. insider buying and selling
Recent open-market trades reported on Form 4. Context only — not a reason to buy or sell.
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-11-06 | Muken Ross | Purchase | 20,000 | $6.86 |
| 2026-11-06 | CARDOZA GEORGE | Purchase | 20,000 | $7.06 |
| 2026-10-13 | Xu Zhenyu | Sale | 4,000 | $7.18 |
| 2026-10-12 | Menu Philippe | Sale | 5,000 | $7.26 |
| 2026-10-12 | Camblong Jurgi | Sale | 8,500 | $7.26 |
| 2026-10-05 | Van Well Daan | Sale | 6,168 | $8.12 |
| 2026-10-05 | Valente Manuela | Sale | 4,240 | $8.13 |
| 2026-10-05 | Verma Abhimanyu | Sale | 5,284 | $8.12 |
SEC filings
No filings stored yet.
Ask anything about SOPHiA GENETICS S.A.'s filings
"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.
Start researching freeCompare SOPH head-to-head
More Healthcare companies
Revvity, Inc. RVTYRhythm Pharmaceuticals, Inc. RYTMSenseonics Holdings, Inc. SENSSight Sciences, Inc. SGHTSol-Gel Technologies Ltd. SLGLSiemens Healthineers AG SMMNYNeuronetics, Inc. STIMStevanato Group S.p.A. STVNStryker Corporation SYKTScan Therapeutics, Inc. TCRXTempus AI, Inc. TEMTeva Pharmaceutical Industries Limited TEVA